Skip to main content

Advertisement

Log in

A retrospective study of unicentric and multicentric Castleman’s disease: a report of 52 patients

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

Castleman’s disease (CD) is a rare disorder characterized by non-cancerous tumor growth that may develop in the lymph node tissue at a single site or throughout the body (Castleman et al. in Cancer 9:822–830, 1956). It involves hyperproliferation of specific B cells that produce the cytokine IL-6. This disorder is often undiagnosed or misdiagnosed. For this reason, only very few patients have been reported, and little information is available in the literature. In hopes of providing a better understanding of this rare disease, this report examines 52 patients with Unicentric Castleman’s disease (UCD) and Multicentric Castleman’s disease (MCD) treated from 1999–2008 at a single institution. Fifty-two patients with CD, along with their histological diagnoses, were collected. Patients were divided into two groups—the more common UCD and the less common MCD. Relevant clinical, pathological, and laboratory data were examined in order to evaluate treatment responses, with symptom onsets and survival period serving as the endpoints of the assessment. Each of the 48 patients with UCD exhibited benign symptoms and underwent a curative surgical resection with excellent prognosis. All of the four patients with MCD received surgical resection. Three of the four patients relapsed and received radiotherapy and/or chemotherapy. Only one of the three post-treatment patients survived. UCD is manifested in the form of benign, painless, slow lymph node enlargement that is generally asymptomatic. Complete surgical removal is recommended as a course of curative treatment. The multicentric form of CD exhibits a progressive clinical course with potential for malignancy. There is currently no standard therapy for MCD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Castleman B, Iverson L, Menendez VP. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer. 1956;9:822–30.

    Article  CAS  PubMed  Google Scholar 

  2. Flendrig JA. Benign giant lymphoma: clinicopathologic correlation study. In: Clark RL, Cumley RW, editors. The year book of cancer, 1970. Chicago: Year Book Medical Publishers; 1970. p. 296–9.

    Google Scholar 

  3. Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer. 1972;29:670–83.

    Article  CAS  PubMed  Google Scholar 

  4. Frizzera G, Massarelli G, Banks PM, Rosai J. A systemic lymphoproliferative disorder with morphologic features of Castleman’s disease: pathological findings in 15 patients. Am J Surg Pathol. 1983;7:211–31.

    Article  CAS  PubMed  Google Scholar 

  5. Peterson BA, Frizzera G. Multicentric Castleman’s disease. Semin Oncol. 1993;20:636–47.

    CAS  PubMed  Google Scholar 

  6. Jeffrey R, McGahan J. Gastrointestinal tract and peritoneal cavity: peritoneal mesenteric tumors. In: McGahan J, Goldberg B, editors. Diagnostic ultrasound: a logical approach. Philadelphia: Lippincott-Raven; 1998. p. 550–4.

    Google Scholar 

  7. Yamashita Y, Hirai T, Matsukawa T, Ogata I, Takahashi M. Radiological presentations of Castleman’s disease. Comput Med Imaging Graph. 1993;17:107–17.

    Article  CAS  PubMed  Google Scholar 

  8. Chronowski GM, Ha CS, Wilder RB, Cabanillas F, Manning J, Cox JD. Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy. Cancer. 2001;92:670–6.

    Article  CAS  PubMed  Google Scholar 

  9. Roca B. Castleman’s disease. A review. AIDS Rev. 2009 Jan–Mar;11:3–7.

  10. Wang H, Wieczorek RL, Zenilman ME, Desoto-Lapaix F, Ghosh BC, Bowne WB. Castleman’s disease in the head of the pancreas: report of a rare clinical entity and current perspective on diagnosis, treatment, and outcome. World J Surg Oncol. 2007;20:133.

    Article  Google Scholar 

  11. Collins LS, Fowler A, Tong CY, de Ruiter A. Multicentric Castleman’s disease in HIV infection. Int J STD AIDS. 2006;17:19–24.

    Article  CAS  PubMed  Google Scholar 

  12. Kojima M, Nakamura S, Miyawaki S, Ohno Y, Sakela N, Majawa N. Progressive transformation of germinal center presenting with histological features of hyaline-vascular type of Castleman’s disease. APMIS. 2005;113:288–95.

    Article  PubMed  Google Scholar 

  13. McCarty MJ, Vukelja SJ, Banks PM, Weiss RB. Angiofollicular lymph node hyperplasia (Castleman’s disease). Cancer Treat Rev. 1995;21:291–310.

    Article  CAS  PubMed  Google Scholar 

  14. Herrada J, Cabanillas F, Rice L, Manning J, Pugh W. Clinical behavior of localized and multicentric Castleman’s disease. Ann Intern Med. 1998;128:657–62.

    CAS  PubMed  Google Scholar 

  15. Ko SF, Wan YL, Ng SH, Lin JW, Hsieh MJ, Fang FM, et al. Imaging features of atypical thoracic Castleman’s disease. Clin Imaging. 2004;28:280–5.

    Article  PubMed  Google Scholar 

  16. Gaba AR, Stein RS, Sweet DL, Variakojis D. Multicentric giant lymph node hyperplasia. Am J Clin Pathol. 1978;69:86–90.

    CAS  PubMed  Google Scholar 

  17. Bowne WB, Lewis JJ, Filippa DA, Niesvizky R, Brooks AD, Burt ME, et al. The management of unicentric and multicentric Castleman’s disease: a report of 16 cases and a review of the literature. Cancer. 1999;85:706–17.

    Article  CAS  PubMed  Google Scholar 

  18. Frizzera G. Castleman’s disease and related disorders. Semin Diag Pathol. 1988;5:346–64.

    CAS  Google Scholar 

  19. Gangopadhyay K, Mahasin ZZ, Kfoury H. Pathologic quiz case 2.Castleman’s disease (giant lymph node hyperplasia). Arch Otolaryngol Head Neck Surg. 1997;123:1137–9.

    CAS  PubMed  Google Scholar 

  20. Johkoh T, Muller NL, Ichikado K, Nishimoto N, Yoshizaki K, Honda O, et al. Intrathoracic multicentric Castleman’s disease: CT findings in 12 patients. Radiology. 1998;209:477–81.

    CAS  PubMed  Google Scholar 

  21. Kunishima S, Taniguchi H, Koh T, Yamaguchi A, Yamagishi H. F-18 fluorodeoxyglucose positron emission tomography in mesenterial Castleman’s lymphoma. Clin Nucl Med. 2001;26:789–90.

    Article  CAS  PubMed  Google Scholar 

  22. Malara F, Price D, Fabiny R. Mesenteric Castleman’s disease: ultrasound, computed tomography and angiographic appearance. Australas Radiol. 2000;44:109–11.

    Article  CAS  PubMed  Google Scholar 

  23. Seco JL, Velasco F, Manuel JS, Serrano SR, Tomas L, Velasco A. Retroperitoneal Castleman’s disease. Surgery. 1992;112:850–5.

    CAS  PubMed  Google Scholar 

  24. Larroche C, Cacoub P, Godeau P. Castleman’s disease. Rev Med Interne. 1996;17:1003–13.

    Article  CAS  PubMed  Google Scholar 

  25. Ebisuno S, Yamauchi T, Fukatani T, Ohkawa T. Retroperitoneal Castleman’s disease: A case report and brief review of tumors of the pararenal area. Urol Int. 1989;44:169–72.

    Article  CAS  PubMed  Google Scholar 

  26. Takihara H, Yamakawa G, Baba Y, Takahashi M, Ishihara T. Castleman disease unusual retroperitoneal location indistinguishable from malignant tumor in preoperative angiographic appearance. Urology. 1993;41:162–4.

    Article  CAS  PubMed  Google Scholar 

  27. Kiguchi H, Ishii T, Ishikawa Y, Masuda S, Asuwa N, Yamafuji K, et al. Castleman’s disease of the abdomen and pelvis: report of three cases and a review of the literature. J Gastroenterol. 1995;30:661–6.

    Article  CAS  PubMed  Google Scholar 

  28. Bartkowski DP, Ferrigni RG. Castleman’s disease: an unusual retroperitoneal mass. J Urol. 1988;139:118–20.

    CAS  PubMed  Google Scholar 

  29. Skolnik G, Wiklund LM, Risberg B. Castleman’s tumor with retroperitoneal location: a malignant appearing benign tumor. J Surg Oncol. 1985;28:153–5.

    Article  CAS  PubMed  Google Scholar 

  30. D’Agay MF, Miclea JM, Clauvel JP. Castleman’s disease: a well defined histological pattern for a widely divergent clinical spectrum. Nouv Rev Fr Hematol. 1989;31:145–8.

    PubMed  Google Scholar 

  31. Nordstrom DG, Tewfik HH, Latourette HB. Plasma cell giant lymph node hyperplasia responding to radiation therapy. Am J Radiol. 1978;130:169–71.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Xiang-Yang Liu or Ke-Ling Sun.

Additional information

Bo Ye and Shu-Geng Gao contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ye, B., Gao, SG., Li, W. et al. A retrospective study of unicentric and multicentric Castleman’s disease: a report of 52 patients. Med Oncol 27, 1171–1178 (2010). https://doi.org/10.1007/s12032-009-9355-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12032-009-9355-0

Keywords

Navigation